newsfilter
← Latest News
PR Newswire·

Stealth BioTherapeutics Announces New SBT-272 Data and Trial Initiation

BOSTON, March 30, 2022 /PRNewswire/ -- Stealth BioTherapeutics Corp (NASDAQ:MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, an